Yu, J
Chen, L
Chen, Y
Hasan, M K
Ghia, E M
Zhang, L
Wu, R
Rassenti, L Z
Widhopf, G F
Shen, Z
Briggs, S P
Kipps, T J
Article History
Received: 30 November 2016
Revised: 3 March 2017
Accepted: 21 March 2017
First Online: 3 May 2017
Competing interests
: Cirmtuzumab was developed in the Kipps laboratory and licensed by Oncternal Therapeutics, Inc., from the University of California, San Diego.